| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $186.4M | +141.8% |
| R&D Expense | $102.6M | -4.0% |
| SG&A Expense | $145.9M | +63.8% |
| Operating Income | -$109.2M | +16.8% |
| Pre-tax Income | -$162.4M | -14.3% |
| Income Tax | $991K | +115.5% |
| Net Income | -$163.4M | -20.5% |
| EPS (Basic) | -$4.00 | +0.2% |
| EPS (Diluted) | -$4.00 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.3M | +922.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $68.0M | +183.3% |
| Inventory | $22.3M | +300.9% |
| Current Assets | $387.5M | +103.7% |
| Total Assets | $646.6M | +83.2% |
| Current Liabilities | $87.1M | +34.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.9M | +40.9% |
| Capital Expenditures | $109K | -60.8% |
| Investing Cash Flow | -$107.2M | -1492.2% |
| Financing Cash Flow | $336.6M | +208.6% |
| Free Cash Flow | -$71.1M | +41.0% |
| +0.5% |
| Total Liabilities |
| $398.0M |
| +88.7% |
| Stockholders' Equity | $248.7M | +75.1% |